Passage Bio, Inc.

NASDAQ:PASG

0.7 (USD) • At close January 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Revenue 0005.91200000000000000000000
Cost of Revenue 00.80.8060.80710.9780.9780.9460.9290.9210.8830.6690.460.2030.211000000000
Gross Profit 0-0.8-0.8065.105-1-0.978-0.978-0.946-0.929-0.921-0.883-0.669-0.46-0.203-0.211000000000
Gross Profit Ratio 0000.86300000000000000000000
Reseach & Development Expenses 8.65610.4311.53512.16115.09817.32416.83617.65715.36226.82126.21332.96826.62333.11224.9727.93220.83719.90213.1179.97210.4346.2993.0335.941
General & Administrative Expenses 7.2516.516.5156.2858.1848.06419.04710.58710.66412.99115.09917.19214.97815.42212.46410.1247.7937.4024.7953.621.2090.9681.1540.481
Selling & Marketing Expenses 00-0.806-0.80700000000000000000000
SG&A 7.2516.515.7095.4788.1848.06419.04710.58710.66412.99115.09917.19214.97815.42212.46410.1247.7937.4024.7953.621.2090.9681.1540.481
Other Expenses 4.7950.4381.3391.6881.5621.5321.54500.8250.270.0010000000000000
Operating Expenses 20.70217.37817.24417.63923.28225.38835.88328.24426.02639.81241.31250.1641.60148.53437.43438.05628.6327.30417.91213.59211.6437.2674.1875.819
Operating Income -20.702-17.378-18.05-18.446-28.672-25.388-35.883-28.244-27.526-39.812-42.812-51.16-47.101-48.534-38.934-39.056-28.63-27.304-17.912-13.592-11.643-7.767-4.187-6.422
Operating Income Ratio 000-3.1200000000000000000000
Total Other Income Expenses Net 1.3621.3871.3391.6881.5621.5321.5451.1730.8250.270.0010.0060.1860.0990.0520.1120.0990.1320.3270.4410.255-5.659-3.4820.603
Income Before Tax -19.34-15.991-16.711-16.758-27.11-23.856-34.338-27.071-26.701-39.542-42.811-51.154-46.915-48.435-38.882-38.944-28.531-27.172-17.585-13.151-11.388-13.426-7.669-5.819
Income Before Tax Ratio 000-2.83500000000000000000000
Income Tax Expense 00-03.481-0.958-0.978-1.545-1.173-0.825-0.27-0.001-0.006-0.186-0.0992.896-0.112-0.099-0.132-0.654-0.441-0.2555.6596.9640.603
Net Income -19.34-15.991-16.711-16.758-27.11-23.856-32.793-25.898-25.876-39.272-42.81-51.154-46.915-48.435-38.882-38.944-28.531-27.172-17.585-13.151-11.388-13.426-7.669-5.819
Net Income Ratio 000-2.83500000000000000000000
EPS -0.31-0.26-0.3-0.31-0.49-0.44-0.6-0.47-0.48-0.72-0.79-0.95-0.87-0.9-0.76-0.85-0.63-0.6-1-0.55-0.48-0.56-0.32-1.47
EPS Diluted -0.31-0.26-0.3-0.31-0.49-0.44-0.6-0.47-0.48-0.72-0.79-0.95-0.87-0.9-0.76-0.85-0.63-0.6-1-0.55-0.48-0.56-0.32-1.47
EBITDA -15.148-16.143-17.244-17.639-22.324-24.41-35.883-26.125-25.097-38.891-40.429-49.491-41.141-48.331-37.223-37.778-28.355-27.106-17.863-13.547-11.602-7.231-4.1750.603
EBITDA Ratio 000-2.98400000000000000000000